References
1. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of
COVID-19-infected cancer patients: A retrospective case study in three
hospitals within Wuhan, China. Annals of Oncology . 2020. doi:
https://doi.org/10.1016/j.annonc.2020.03.296
2. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2
infection: a nationwide analysis in China. The Lancet Oncology .
2020;21 (3):335-37. doi:
https://doi.org/10.1016/S1470-2045(20)30096-6
3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA .
Published online February 24, 2020. doi: 10.1001/jama.2020.2648
4. Yong-Cong C, Wang W, Li C, et al. Treating head and neck tumors
during the SARS-CoV-2 epidemic, 2019-2020: Sichuan Cancer Hospital.Authorea . April 01, 2020. doi:
https://doi.org/10.22541/au.158576817.72109459
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A
Cancer Journal for Clinicians . 2020;70 :7-30. doi:
https://doi.org/10.3322/caac.21590
6. Schutte HW, Heutink F, Wellenstein DJ, et al. Impact of Time to
Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review.Otolaryngology–Head and Neck Surgery . 2020. doi:
https://doi.org/10.1177%2F0194599820906387
7. Murphy CT, Galloway TJ, Handorf EA, et al. Survival Impact of
Increasing Time to Treatment Initiation for Patients With Head and Neck
Cancer in the United States. Journal of Clinical Oncology .
2016;34 (2):169-78. doi:
https://dx.doi.org/10.1200%2FJCO.2015.61.5906
8. Givi B, Schiff BA, Chinn SB, et al. Safety Recommendations for
Evaluation and Surgery of the Head and Neck During the COVID-19
Pandemic. JAMA Otolaryngology–Head & Neck Surgery . Published
online March 31, 2020. doi: doi:10.1001/jamaoto.2020.0780
9. Vargas M, Servillo G. Improving staff safety during tracheostomy in
COVID-19 patients. Authorea . March 31, 2020. doi:
https://doi.org/10.22541/au.158567936.68111075
10. Rassekh CH, Jenks CM, Ochroch EA, Douglas JE, O’Malley Jr. BW,
Weinstein GS. Management of the Difficult Airway in the COVID-19
Pandemic: An Illustrative Complex Head and Neck Case Scenario.Authorea . April 02, 2020. doi:
https://doi.org/10.22541/au.158585426.67421372
11. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol
Generating Procedures and Risk of Transmission of Acute Respiratory
Infections to Healthcare Workers: A Systematic Review. PLoS ONE .
2012;7 (4):e35797. doi:
https://dx.doi.org/10.1371%2Fjournal.pone.0035797
12. Europe’s Doctors Repeat Errors Made in Wuhan, China Medics Say.
Bloomberg News. Published March 17, 2020. Accessed April 5, 2020.
https://www.bloomberg.com/news/articles/2020-03-17/europe-s-doctors-getting-sick-like-in-wuhan-chinese-doctors-say
13. Workman AD, Welling DB, Carter BS, et al. Endonasal instrumentation
and aerosolization risk in the era of COVID-19: simulation, literature
review, and proposed mitigation strategies. International Forum of
Allergy & Rhinology . 2020. doi:
https://doi.org/10.1002/alr.22577
14. Kowalski LP. COVID-19 pandemic: effects and evidence-based
recommendations for otolaryngology and head and neck surgery practice.Authorea . March 31, 2020. doi:
https://doi.org/10.22541/au.158567937.74092406
15. Bann DV, Patel VA, Saadi R, et al. Impact of Coronavirus (COVID-19)
on Otolaryngologic Surgery: A Brief Commentary. Authorea . March
31, 2020. doi: https://doi.org/10.22541/au.158567936.61156499
16. Schreiber RD, Old LJ, Smyth MJ. Cancer Immunoediting: Integrating
Immunity’s Roles in Cancer Suppression and Promotion. Science .
2011;331 (6024):1565-70. doi: 10.1126/science.1203486
17. Schoenfeld JD. Immunity in Head and Neck Cancer. Cancer
Immunology Research . 2015;3 (1):12-17. doi:
https://dx.doi.org/10.1158/2326-6066.CIR-14-0205
18. Preliminary Estimates of the Prevalence of Selected Underlying
Health Conditions Among Patients with Coronavirus Disease 2019 —
United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly
Rep . 2020;69 :382–86. doi:
http://dx.doi.org/10.15585/mmwr.mm6913e2
19. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA. Surgery induced
immunosuppression. The Surgeon . 2011;9 (1):38-43. doi:
https://doi.org/10.1016/j.surge.2010.07.011
20. Carvalho HdA, Villar RC. Radiotherapy and immune response: the
systemic effects of a local treatment. Clinics (Sao Paulo) .
2018;73 (suppl 1):e557s. doi: 10.6061/clinics/2018/e557s
21. Verastegui EL, Morales RB, Barrera-Franco JL, Poitevin AC, Hadden J.
Long-term immune dysfunction after radiotherapy to the head and neck
area. Int Immunopharmacol . 2003;3 (8):1093-104. doi:
https://doi.org/10.1016/S1567-5769(03)00013-4
22. Vermorken JB, Remenar E, Van Herpen C, et al. Cisplatin,
Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer.New England Journal of Medicine . 2007;357 (17):1695-704.
doi: 10.1056/NEJMoa071028
23. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and
Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. New
England Journal of Medicine . 2007;357 (17):1705-15. doi: DOI:
10.1056/NEJMoa070956
24. Izawa N, Onozawa Y, Hikosaka T, et al. Efficacy and feasibility of
docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for
locally advanced head and neck squamous cell carcinoma classified as
clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node
metastases. Int J Clin Oncol . 2015;20 (3):455-62. doi:
https://doi.org/10.1007/s10147-014-0749-4
25. Rasmussen L, Arvin A. Chemotherapy-induced immunosuppression.Environmental Health Perspectives . 1982;43 :21-25. doi:
https://doi.org/10.1289/ehp.824321
26. Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine
and hydroxychloroquine as available weapons to fight COVID-19. Int
J Antimicrob Agents . 2020:105932. doi:
https://doi.org/10.1016/j.ijantimicag.2020.105932
27. Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and
azithromycin as a treatment of COVID-19: results of an open-label
non-randomized clinical trial. Int J Antimicrob Agents .
2020:105949. doi:
https://doi.org/10.1016/j.ijantimicag.2020.105949
28. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine
effectively inhibit the recently emerged novel coronavirus (2019-nCoV)
in vitro. Cell Res . 2020;30 (3):269-71. doi:
https://dx.doi.org/10.1038%2Fs41422-020-0282-0
29. Information for Clinicians on Therapeutic Options for COVID-19
Patients. CDC: Centers for Disease Control and Prevention. Updated March
21, 2020. Accessed April 5, 2020.
https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html
30. New Recommendations Regarding Urgent and Nonurgent Patient Care.
American Academy of Otolaryngology-Head and Neck Surgery. Accessed April
3, 2020.
https://www.entnet.org/content/new-recommendations-regarding-urgent-and-nonurgent-patient-care
31. Ueda M, Martins R, Hendrie P, et al. Managing Cancer Care During the
COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.J Natl Compr Canc Netw .18 (4):1–4. doi:
10.6004/jnccn.2020.7560
32. Siddiqui S. CMS adult elective surgery and procedures
recommendations: limit all non-essential planned surgeries and
procedures, including dental, until further notice. Published Mar 18,
2020. Accessed April 3, 2020.
https://www.cms.gov/files/document/31820-cms-adult-elective-surgery-and-procedures-recommendations.pdf